Infectious Disease
Payments companies reported to CMS as associated with Infectious Disease. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Infectious Disease, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Infectious Disease
These are the largest totals companies reported as associated with Infectious Disease. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Eric Topol | La Jolla, CA | Cardiovascular Disease | $22,990.00 |
| Stuart Sealfon | New York, NY | Neurology (Psychiatry & Neurology) | $5,857.26 |
| Nathaly Sweeney | La Jolla, CA | Neonatal-Perinatal Medicine | $2,068.00 |
| Jay Wohlgemuth | San Juan Capistrano, CA | General Practice | $1,782.50 |
| Peter Hulick | Evanston, IL | Clinical Genetics (M.D.) | $114.74 |
| David Brumbaugh | Aurora, CO | Pediatric Gastroenterology | $114.74 |
| Valerie Arboleda | Los Angeles, CA | Anatomic Pathology & Clinical Pathology | $42.09 |
| Christopher Cutie | Boston, MA | Urology | $39.42 |
| Daniel Jernigan | Atlanta, GA | Internal Medicine | $22.93 |
| Robert Kadlec | Alexandria, VA | Public Health & General Preventive Medicine | $13.61 |
Prescribed Infectious Disease?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.